ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,285 | -10.5% | 153,000 | 0.0% | 0.35% | -8.8% |
| Q2 2023 | $4,788 | +11.0% | 153,000 | 0.0% | 0.39% | +5.5% |
| Q1 2023 | $4,313 | +7.9% | 153,000 | 0.0% | 0.37% | +4.6% |
| Q4 2022 | $3,997 | -99.9% | 153,000 | 0.0% | 0.35% | +13.6% |
| Q3 2022 | $3,416,000 | -25.0% | 153,000 | 0.0% | 0.31% | -19.6% |
| Q2 2022 | $4,557,000 | +13.2% | 153,000 | 0.0% | 0.38% | +35.3% |
| Q1 2022 | $4,025,000 | +13.1% | 153,000 | 0.0% | 0.28% | +12.7% |
| Q4 2021 | $3,558,000 | -24.6% | 153,000 | 0.0% | 0.25% | -31.8% |
| Q3 2021 | $4,718,000 | +25.8% | 153,000 | 0.0% | 0.37% | +25.6% |
| Q2 2021 | $3,751,000 | +31.9% | 153,000 | +0.5% | 0.29% | +22.6% |
| Q1 2021 | $2,843,000 | -6.4% | 152,200 | 0.0% | 0.24% | -11.8% |
| Q4 2020 | $3,036,000 | +28.9% | 152,200 | +7.0% | 0.27% | +15.3% |
| Q3 2020 | $2,356,000 | -14.6% | 142,200 | 0.0% | 0.24% | -22.4% |
| Q2 2020 | $2,759,000 | +428.5% | 142,200 | +292.8% | 0.30% | +332.9% |
| Q1 2020 | $522,000 | +58.2% | 36,200 | +123.5% | 0.07% | +105.9% |
| Q4 2019 | $330,000 | +4.4% | 16,200 | 0.0% | 0.03% | -2.9% |
| Q3 2019 | $316,000 | +52.7% | 16,200 | +76.1% | 0.04% | +52.2% |
| Q2 2019 | $207,000 | -30.8% | 9,200 | +12.2% | 0.02% | -30.3% |
| Q1 2019 | $299,000 | +23.6% | 8,200 | 0.0% | 0.03% | +6.5% |
| Q4 2018 | $242,000 | -30.5% | 8,200 | 0.0% | 0.03% | -20.5% |
| Q3 2018 | $348,000 | +3.0% | 8,200 | 0.0% | 0.04% | -4.9% |
| Q2 2018 | $338,000 | -28.8% | 8,200 | 0.0% | 0.04% | -31.7% |
| Q1 2018 | $475,000 | +5.8% | 8,200 | 0.0% | 0.06% | +7.1% |
| Q4 2017 | $449,000 | +7.7% | 8,200 | 0.0% | 0.06% | +5.7% |
| Q3 2017 | $417,000 | -12.2% | 8,200 | 0.0% | 0.05% | -15.9% |
| Q2 2017 | $475,000 | -1.0% | 8,200 | 0.0% | 0.06% | -3.1% |
| Q1 2017 | $480,000 | +5.3% | 8,200 | 0.0% | 0.06% | -1.5% |
| Q4 2016 | $456,000 | +10.1% | 8,200 | -6.8% | 0.07% | +6.5% |
| Q3 2016 | $414,000 | -2.4% | 8,800 | -10.2% | 0.06% | -6.1% |
| Q2 2016 | $424,000 | +32.1% | 9,800 | +4.3% | 0.07% | +26.9% |
| Q1 2016 | $321,000 | -65.6% | 9,400 | -20.0% | 0.05% | -66.9% |
| Q4 2015 | $933,000 | +127.0% | 11,750 | +67.9% | 0.16% | +121.1% |
| Q3 2015 | $411,000 | -8.7% | 7,000 | 0.0% | 0.07% | +7.6% |
| Q2 2015 | $450,000 | +5.4% | 7,000 | 0.0% | 0.07% | +8.2% |
| Q1 2015 | $427,000 | +4.1% | 7,000 | 0.0% | 0.06% | +3.4% |
| Q4 2014 | $410,000 | +36.7% | 7,000 | 0.0% | 0.06% | +28.3% |
| Q3 2014 | $300,000 | -14.8% | 7,000 | 0.0% | 0.05% | -6.1% |
| Q2 2014 | $352,000 | +13.9% | 7,000 | 0.0% | 0.05% | +6.5% |
| Q1 2014 | $309,000 | +8.4% | 7,000 | 0.0% | 0.05% | -4.2% |
| Q4 2013 | $285,000 | +21.3% | 7,000 | 0.0% | 0.05% | +17.1% |
| Q3 2013 | $235,000 | +16.9% | 7,000 | 0.0% | 0.04% | +32.3% |
| Q2 2013 | $201,000 | – | 7,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |